0.2989
Accuray Inc stock is traded at $0.2989, with a volume of 35,531.
It is up +2.05% in the last 24 hours and up +19.31% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$0.2924
Open:
$0.293
24h Volume:
35,531
Relative Volume:
0.01
Market Cap:
$35.72M
Revenue:
$436.97M
Net Income/Loss:
$-35.62M
P/E Ratio:
-1.002
EPS:
-0.2983
Net Cash Flow:
$-10.71M
1W Performance:
+7.26%
1M Performance:
+19.31%
6M Performance:
-44.26%
1Y Performance:
-80.87%
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ARAY
Accuray Inc
|
0.2991 | 35.21M | 436.97M | -35.62M | -10.71M | -0.2983 |
|
ABT
Abbott Laboratories
|
114.59 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.78 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.17 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.50 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
Accuray Fiscal Q4 Swings to Loss, Revenue Falls - Moomoo
ARAY|Accuray Inc|Price:0.295|Chg%:-0.020 - TradingKey
Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic - GuruFocus
ARAY Looks 77.3% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Accuray Incorporated Q4 2026 Earnings Call Summary - Yahoo Finance
Accuray earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Aug 19 (Reuters)Accuray Incorporated Q4 Ne - Moomoo
Accuray (ARAY) Telefonkonferenz zu den Ergebnissen des 4. Quartals des Geschäftsjahres 2026: Servicewachstum, Rückgang der Produktumsätze - TradingKey
Earnings call transcript: Accuray posts mixed Q4 2026 results as revenue slips - Investing.com
Accuray Q4 2026 Earnings Call: Complete Transcript - Benzinga
Accuray Incorporated reports results for the quarter ended June 30Earnings Summary - TradingView
Is Accuray Inc (ARAY) a Value Trap After Q4 Earnings Miss? EPS - GuruFocus
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results - Investing News Network
Accuray Q4 Results: EPS beats estimate, sales miss by 4.16% - scanx.trade
ARAY Looks 78.0% Undervalued on GF Value™ but Faces Profitabilit - GuruFocus
ARAY Looks 78.0% Undervalued on GF Value™ - GuruFocus
Accuray: Fiscal Q4 Earnings Snapshot - marketscreener.com
Accuray posts narrower-than-feared Q4 loss as cost cuts exceed targets - Investing.com Canada
Accuray Q4 FY2026 Earnings: Margin Expands Despite Product Revenue Decline - TradingKey
Accuray Reports $100.9 Million Fourth-Quarter Revenue and $1.9 Million Net Loss - Quiver Quantitative
BRIEF-Accuray Incorporated Q4 Revenue USD 100.919 Million - TradingView
Accuray Incorporated Reports Earnings Results for the Fourth Quarter Ended June 30, 2026 - marketscreener.com
Accuray Q4 FY26 slides: service gains offset product revenue drop By Investing.com - Investing.com Canada
Accuray (ARAY) Trading Summary: Falls 3.55% to $0.32 for the Current Session; Session Range View: Support at $0.30 and Resistance at $0.34 Frame the Range in the Available RecordHidden Order - Vinanet
ARAY Looks 76.5% Undervalued on GF Value™ - GuruFocus
Accuray Incorporated expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Earnings Preview: Accuray to Report Financial Results Post-market on August 19 - Moomoo
Accuray Inc (ARAY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments - TradingView
Accuray names two executives to lead transformation efforts By Investing.com - Investing.com Canada
Accuray (NASDAQ: ARAY) seeks approval for $55M recapitalization, dilution and reverse split - Stock Titan
Accuray | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
Accuray Incorporated Announces Executive Appointments - marketscreener.com
Accuray Inc (ARAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Neuberger Berman Group LLC Trims Accuray Inc (ARAY) Stake -- Sha - GuruFocus
Primer: Accuray Inc (ARAY US)Aug 2026 - Smartkarma
Accuray Transfers Listing to Nasdaq Capital Market - The Globe and Mail
Accuray Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Radiation therapy company Accuray will discuss results Aug. 19 - Stock Titan
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026 - marketscreener.com
Neuberger Berman Group (ARAY) discloses 5.48M Accuray shares in 13G/A filing - Stock Titan
Accuray | SCHEDULE 13G/A: Others - Moomoo
Accuray Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Form S-3 Accuray Incorporated For: 31 July By Investing.com - Investing.com Nigeria
Accuray Inc (ARAY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Accuray swaps $40M debt for equity, raises $15M cash from TCW - scanx.trade
Beverly Huss and Anne LeGrand resign from Accuray board - TradingView
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation - PR Newswire
Accuray Inc (ARAY) Institutional Confidence - TradingKey
Accuray Incorporated announced that it expects to receive $15 million in funding - marketscreener.com
Accuray Inc (ARAY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accuray Inc Stock (ARAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):